O’Melveny has advised Heartflow, Inc. Heartflow, Inc., a leader in AI technology for coronary artery disease, has completed its upsized initial public offering of 16,666,667 shares...
O’Melveny has advised Heartflow, Inc. Heartflow, Inc., a leader in AI technology for coronary artery disease, has completed its upsized initial public offering of 16,666,667 shares...
